Description | History of study cases (specimen type: blood) | % | History of study cases (specimen type: tissue) | % |
---|---|---|---|---|
Number of samples | 43/52 | 82.69 | 9/52 | 17.31 |
Age range (years) | ||||
 30–39 | 13/43 | 30.23 | 3/9 | 33.33 |
 40–49 | 16/43 | 37.21 | 3/9 | 33.33 |
 50–70 | 14/43 | 32.56 | 3/9 | 33.33 |
Clinical information | ||||
 Breast Cancer | 23/43 | 53.49 | 9/9 | 100.00 |
  Stage I | 5/23 | 21.74 | 0/9 | 0.00 |
  Stage II | 12/23 | 52.17 | 5/9 | 55.55 |
  Stage III | 6/23 | 26.09 | 2/9 | 22.22 |
  Stage unknown | N/A | N/A | 2/9 | 22.22 |
  Grade I | 3/23 | 13.04 | – | – |
  Grade II | 13/23 | 56.52 | – | – |
  Grade III | 6/23 | 26.09 | – | – |
  Grade unknown | 1/23 | 4.35 | 9/9 | 100 |
Breast lump | 11/43 | 25.58 | – | – |
Breast pain and secretion | 5/43 | 11.63 | – | – |
No symptoms | 4/43 | 9.30 | – | – |
Family History | ||||
Positive | 38/43 | 88.37 | 2/9 | 22.22 |
Negative | 5/43 | 11.63 | 3/9 | 33.33 |
Unknown | – | – | 4/9 | 44.44 |
Mutation found(including VUS and Pathogenic) | 11/43 | 25.58 | 3/9 (1 patient carried 2 mutations. So total number of mutations in 3 patients are 4) | 33.33 |
BRCA1(V + P) | 4/43 | 9.30 | 1/9 | 33.33 |
BRCA2(V + P) | 6/43 | 13.95 | 1/9 | 33.33 |
TP53(P) | – | – | 2/9 | 22.22 |
ERBB2(V) | 1/43 | 2.32 | – | – |